All News

COMT inhibitor to be used as an adjunctive treatment to levodopa/carbidopa.

New study examines effective implementation of team-based care in community pharmacies. 

Changes fueled by the 2003 Medicare Prescription Drug Improvement and Modernization Act.

CBD market will grow by over 700% in 2019.

25 murder charges against one physician leads to multiple firings at Ohio hospital.

Comprehensive medication management may lower costs and improve lives. 

Rule would cost $177 billion through 2029.

Results from new ASHP Survey.

By 2020, industry experts believe specialty drugs will account for 50% of U.S. spending on pharmaceuticals.

Pharmacists need to remain vigilant about HIV with testing, prevention, treatment, and education of HIV.

Shingles is associated with a statistically significant increase in the risk of myocardial infarction, stroke, and transient ischemic attack.

3% of nationwide pharmacy staff laid of nationwide; nearly half were senior pharmacists.

At the 2019 Asembia Specialty Pharmacy Summit, former FDA Commissioner Scott Gottlieb discussed advances within the agency during his tenure.

Value-based programs emphasize better care, enhanced health, and lower costs. 

3.5 million Americans estimated to be living with chronic HCV infection, but half may not know. 

Affordable dispensing robots are opening new opportunities for community pharmacies.

Nuclear export inhibitor indicated in combination with dexamethasone.

New technology is making it possible to predict and respond to COPD flare ups. 

Working in an office may be a greater COPD risk than working in a mine. 

$359 million per year, and nearly 40 cumulative hours per week are spent mitigating shortages.

Unsupported claims of safety and effectiveness have concnerned the FDA. 

Pilot program will include a blockchain-secured distribution.

Now approved to be used in combiantion with lenalidomide and dexamethasone. 

Bevacizumab-bvzr is an mAb endothelial growth factor biosimilar.

Patient data provides a rich resource that can help address the problem of opioid misuse and addiction among their health plan members.